{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T15:59:18Z","timestamp":1781366358243,"version":"3.54.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Heilavernd"},{"name":"Arctic Therapeutics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-026-02233-x","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T05:17:03Z","timestamp":1769491023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Basement membrane remodeling with fibroblast activation and cystatin C aggregation in cerebral vessels of hereditary cystatin C amyloid angiopathy"],"prefix":"10.1186","volume":"14","author":[{"given":"Asbjorg Osk","family":"Snorradottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hjalti Karl","family":"Hafsteinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Hansdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saevar","family":"Ingthorsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurdur Runar","family":"Gudmundsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Skodras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi J.","family":"Isaksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakon","family":"Hakonarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"2233_CR1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/ncomms1734","volume":"3","author":"A Akhmetshina","year":"2012","unstructured":"Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J et al (2012) Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun 3:735. https:\/\/doi.org\/10.1038\/ncomms1734","journal-title":"Nat Commun"},{"key":"2233_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00001","volume":"11","author":"R Aldea","year":"2019","unstructured":"Aldea R, Weller RO, Wilcock DM, Carare RO, Richardson G (2019) Cerebrovascular smooth muscle cells as the drivers of intramural periarterial drainage of the brain. Front Aging Neurosci 11:1. https:\/\/doi.org\/10.3389\/fnagi.2019.00001","journal-title":"Front Aging Neurosci"},{"key":"2233_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2990.2010.01137.x","volume":"37","author":"J Attems","year":"2011","unstructured":"Attems J, Jellinger K, Thal DR, Van Nostrand W (2011) Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 37:75\u201393. https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01137.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2233_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","volume":"12","author":"J Attems","year":"2014","unstructured":"Attems J, Jellinger KA (2014) The overlap between vascular disease and Alzheimer\u2019s disease\u2013lessons from pathology. BMC Med 12:206. https:\/\/doi.org\/10.1186\/s12916-014-0206-2","journal-title":"BMC Med"},{"key":"2233_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228764","author":"A Badran","year":"2020","unstructured":"Badran A, Nasser SA, Mesmar J, El-Yazbi AF, Bitto A, Fardoun MM, Baydoun E, Eid AH (2020) Reactive oxygen species: modulators of phenotypic switch of vascular smooth muscle cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21228764","journal-title":"Int J Mol Sci"},{"key":"2233_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/brb3.208","volume":"4","author":"R Bavarsad Shahripour","year":"2014","unstructured":"Bavarsad Shahripour R, Harrigan MR, Alexandrov AV (2014) N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain Behav 4:108\u2013122. https:\/\/doi.org\/10.1002\/brb3.208","journal-title":"Brain Behav"},{"key":"2233_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/BF01605784","volume":"417","author":"E Benedikz","year":"1990","unstructured":"Benedikz E, Blondal H, Gudmundsson G (1990) Skin deposits in hereditary cystatin C amyloidosis. Virchows Arch A Pathol Anat Histopathol 417:325\u2013331. https:\/\/doi.org\/10.1007\/BF01605784","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"2233_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccb.2022.100124","volume":"3","author":"A Biffi","year":"2022","unstructured":"Biffi A (2022) Main features of hereditary cerebral amyloid angiopathies: a systematic review. Cereb Circ Cogn Behav 3:100124. https:\/\/doi.org\/10.1016\/j.cccb.2022.100124","journal-title":"Cereb Circ Cogn Behav"},{"key":"2233_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13506120108993809","volume":"8","author":"M Bjarnadottir","year":"2001","unstructured":"Bjarnadottir M, Nilsson C, Lindstr\u00f6m V, Westman A, Davidsson P, Thormodsson F, Bl\u00f6ndal H, Gudmundsson G, Grubb A (2001) The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids. Amyloid 8:1\u201310. https:\/\/doi.org\/10.3109\/13506120108993809","journal-title":"Amyloid"},{"key":"2233_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/mp.51.6.317","volume":"51","author":"M Bjarnadottir","year":"1998","unstructured":"Bjarnadottir M, Wulff BS, Sameni M, Sloane BF, Keppler D, Grubb A, Abrahamson M (1998) Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH\/3T3 cells. Mol Pathol 51:317\u2013326. https:\/\/doi.org\/10.1136\/mp.51.6.317","journal-title":"Mol Pathol"},{"key":"2233_CR11","first-page":"157","volume":"317","author":"H Blondal","year":"1989","unstructured":"Blondal H, Gudmundsson G, Benedikz E, Johannesson G (1989) Dementia in hereditary cystatin c amyloidosis. Prog Clin Biol Res 317:157\u2013164","journal-title":"Prog Clin Biol Res"},{"key":"2233_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/nan.12042","volume":"39","author":"RO Carare","year":"2013","unstructured":"Carare RO, Hawkes CA, Jeffrey M, Kalaria RN, Weller RO (2013) Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol Appl Neurobiol 39:593\u2013611. https:\/\/doi.org\/10.1111\/nan.12042","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2233_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-1-48","volume":"1","author":"RO Carare","year":"2013","unstructured":"Carare RO, Teeling JL, Hawkes CA, Puntener U, Weller RO, Nicoll JA, Perry VH (2013) Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer\u2019s disease. Acta Neuropathol Commun 1:48. https:\/\/doi.org\/10.1186\/2051-5960-1-48","journal-title":"Acta Neuropathol Commun"},{"key":"2233_CR14","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1212\/WNL.0000000000004259","volume":"89","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Imaizumi T, Moulin S, Biffi A, Samarasekera N, Yakushiji Y, Peeters A, Vandermeeren Y, Laloux P, Baron JC et al (2017) Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis. Neurology 89:820\u2013829. https:\/\/doi.org\/10.1212\/WNL.0000000000004259","journal-title":"Neurology"},{"key":"2233_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022210","author":"MJ Goumans","year":"2018","unstructured":"Goumans MJ, Ten Dijke P (2018) TGF-beta signaling in control of cardiovascular function. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a022210","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2233_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/bpa.12533","volume":"28","author":"L Grand Moursel","year":"2018","unstructured":"Grand Moursel L, Munting LP, van der Graaf LM, van Duinen SG, Goumans MTH, Ueberham U, Natte R, van Buchem MA, van Roon-Mom WMC, van der Weerd L (2018) TGF\u03b2 pathway deregulation and abnormal phospho\u2010SMAD2\/3 staining in hereditary cerebral hemorrhage with amyloidosis\u2010Dutch type. Brain Pathol 28:495\u2013506. https:\/\/doi.org\/10.1111\/bpa.12533","journal-title":"Brain Pathol"},{"key":"2233_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ (2020) Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol 16:30\u201342. https:\/\/doi.org\/10.1038\/s41582-019-0281-2","journal-title":"Nat Rev Neurol"},{"key":"2233_CR18","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1161\/STROKEAHA.124.044293","volume":"55","author":"SM Greenberg","year":"2024","unstructured":"Greenberg SM, van Veluw SJ (2024) Cerebral amyloid angiopathy. Stroke 55:1409\u20131411. https:\/\/doi.org\/10.1161\/STROKEAHA.124.044293","journal-title":"Stroke"},{"key":"2233_CR19","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/Nejm198412133112406","volume":"311","author":"A Grubb","year":"1984","unstructured":"Grubb A, Jensson O, Gudmundsson G, Arnason A, Lofberg H, Malm J (1984) Abnormal-metabolism of gamma-trace alkaline microprotein - the basic defect in hereditary cerebral-hemorrhage with amyloidosis. N Engl J Med 311:1547\u20131549. https:\/\/doi.org\/10.1056\/Nejm198412133112406","journal-title":"N Engl J Med"},{"key":"2233_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/bpa.12159","volume":"24","author":"CA Hawkes","year":"2014","unstructured":"Hawkes CA, Jayakody N, Johnston DA, Bechmann I, Carare RO (2014) Failure of perivascular drainage of beta-amyloid in cerebral amyloid angiopathy. Brain Pathol 24:396\u2013403. https:\/\/doi.org\/10.1111\/bpa.12159","journal-title":"Brain Pathol"},{"key":"2233_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1042\/CS20170004","volume":"131","author":"F Held","year":"2017","unstructured":"Held F, Morris AWJ, Pirici D, Niklass S, Sharp MMG, Garz C, Assmann A, Heinze HJ, Schreiber F, Carare RO et al (2017) Vascular basement membrane alterations and beta-amyloid accumulations in an animal model of cerebral small vessel disease. Clin Sci Lond 131:1001\u20131013. https:\/\/doi.org\/10.1042\/CS20170004","journal-title":"Clin Sci Lond"},{"key":"2233_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.601320","volume":"11","author":"MD Howe","year":"2020","unstructured":"Howe MD, McCullough LD, Urayama A (2020) The role of basement membranes in cerebral amyloid angiopathy. Front Physiol 11:601320. https:\/\/doi.org\/10.3389\/fphys.2020.601320","journal-title":"Front Physiol"},{"key":"2233_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/alz.12366","volume":"18","author":"L Jakel","year":"2022","unstructured":"Jakel L, De Kort AM, Klijn CJM, Schreuder F, Verbeek MM (2022) Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimers Dement 18:10\u201328. https:\/\/doi.org\/10.1002\/alz.12366","journal-title":"Alzheimers Dement"},{"key":"2233_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S1474-4422(23)00114-X","volume":"22","author":"EA Koemans","year":"2023","unstructured":"Koemans EA, Chhatwal JP, van Veluw SJ, van Etten ES, van Osch MJP, van Walderveen MAA, Sohrabi HR, Kozberg MG, Shirzadi Z, Terwindt Ga (2023) Progression of cerebral amyloid angiopathy: a pathophysiological framework. Lancet Neurol 22:632\u2013642. https:\/\/doi.org\/10.1016\/S1474-4422(23)00114-X","journal-title":"Lancet Neurol"},{"key":"2233_CR25","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/JCI33950","volume":"119","author":"M Konigshoff","year":"2009","unstructured":"Konigshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, Rose F, Fink L, Seeger W, Schaefer L et al (2009) WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 119:772\u2013787. https:\/\/doi.org\/10.1172\/JCI33950","journal-title":"J Clin Invest"},{"key":"2233_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf186","volume":"7","author":"MG Kozberg","year":"2025","unstructured":"Kozberg MG, Munting LP, Hanlin LH, Auger CA, van den Berg ML, de Denis Senneville B, Hirschler L, Warnking JM, Barbier EL, Farrar CT et al (2025) Vasomotion loss precedes impaired cerebrovascular reactivity and microbleeds in cerebral amyloid angiopathy. Brain Commun 7:fcaf186. https:\/\/doi.org\/10.1093\/braincomms\/fcaf186","journal-title":"Brain Commun"},{"key":"2233_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G (2022) Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 7:3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6","journal-title":"Signal Transduct Target Ther"},{"key":"2233_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2009.09.026","volume":"48","author":"RM Liu","year":"2010","unstructured":"Liu RM, Gaston Pravia KA (2010) Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radic Biol Med 48:1\u201315. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.09.026","journal-title":"Free Radic Biol Med"},{"key":"2233_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3109\/00365517909108866","volume":"39","author":"H Lofberg","year":"1979","unstructured":"Lofberg H, Grubb AO (1979) Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest 39:619\u2013626. https:\/\/doi.org\/10.3109\/00365517909108866","journal-title":"Scand J Clin Lab Invest"},{"key":"2233_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/01.str.18.2.431","volume":"18","author":"H Lofberg","year":"1987","unstructured":"Lofberg H, Grubb AO, Nilsson EK, Jensson O, Gudmundsson G, Blondal H, Arnason A, Thorsteinsson L (1987) Immunohistochemical characterization of the amyloid deposits and quantitation of pertinent cerebrospinal fluid proteins in hereditary cerebral hemorrhage with amyloidosis. Stroke 18:431\u2013440. https:\/\/doi.org\/10.1161\/01.str.18.2.431","journal-title":"Stroke"},{"key":"2233_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22120-4","volume":"12","author":"ME March","year":"2021","unstructured":"March ME, Gutierrez-Uzquiza A, Snorradottir AO, Matsuoka LS, Balvis NF, Gestsson T, Nguyen K, Sleiman PMA, Kao C, Isaksson HJ et al (2021) NAC blocks cystatin C amyloid complex aggregation in a cell system and in skin of HCCAA patients. Nat Commun 12:1827. https:\/\/doi.org\/10.1038\/s41467-021-22120-4","journal-title":"Nat Commun"},{"key":"2233_CR32","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massague","year":"2012","unstructured":"Massague J (2012) Tgfbeta signalling in context. Nat Rev Mol Cell Biol 13:616\u2013630. https:\/\/doi.org\/10.1038\/nrm3434","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2233_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H (2017) Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell 169:985\u2013999. https:\/\/doi.org\/10.1016\/j.cell.2017.05.016","journal-title":"Cell"},{"key":"2233_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3109\/13506120009146827","volume":"7","author":"I Olafsson","year":"2000","unstructured":"Olafsson I, Grubb A (2000) Hereditary cystatin C amyloid angiopathy. Amyloid 7:70\u201379. https:\/\/doi.org\/10.3109\/13506120009146827","journal-title":"Amyloid"},{"key":"2233_CR35","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/archneur.57.6.869","volume":"57","author":"JM Olichney","year":"2000","unstructured":"Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thal LJ (2000) Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol 57:869\u2013874. https:\/\/doi.org\/10.1001\/archneur.57.6.869","journal-title":"Arch Neurol"},{"key":"2233_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094352","author":"A Ontawong","year":"2025","unstructured":"Ontawong A, Nehra G, Maloney BJ, Vaddhanaphuti CS, Bauer B, Hartz AMS (2025) N-Acetylcysteine attenuates abeta-mediated oxidative stress, blood-brain barrier leakage, and renal dysfunction in 5xFAD mice. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26094352","journal-title":"Int J Mol Sci"},{"key":"2233_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.brainres.2015.06.019","volume":"1622","author":"A Osk Snorradottir","year":"2015","unstructured":"Osk Snorradottir A, Isaksson HJ, Kaeser SA, Skodras AA, Olafsson E, Palsdottir A, Thor Bragason B (2015) Parenchymal cystatin C focal deposits and glial scar formation around brain arteries in Hereditary Cystatin C Amyloid Angiopathy. Brain Res 1622:149\u2013162. https:\/\/doi.org\/10.1016\/j.brainres.2015.06.019","journal-title":"Brain Res"},{"key":"2233_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/s0140-6736(88)90641-1","volume":"2","author":"A Palsdottir","year":"1988","unstructured":"Palsdottir A, Abrahamson M, Thorsteinsson L, Arnason A, Olafsson I, Grubb A, Jensson O (1988) Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 2:603\u2013604. https:\/\/doi.org\/10.1016\/s0140-6736(88)90641-1","journal-title":"Lancet"},{"key":"2233_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000099","volume":"4","author":"A Palsdottir","year":"2008","unstructured":"Palsdottir A, Helgason A, Palsson S, Bjornsson HT, Bragason BT, Gretarsdottir S, Thorsteinsdottir U, Olafsson E, Stefansson K (2008) A drastic reduction in the life span of cystatin C L68Q carriers due to life-style changes during the last two centuries. PLoS Genet 4:e1000099. https:\/\/doi.org\/10.1371\/journal.pgen.1000099","journal-title":"PLoS Genet"},{"key":"2233_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.17992\/lbl.2022.12.721","volume":"108","author":"A Palsdottir","year":"2022","unstructured":"Palsdottir A, Snorradottir AO, Hakonarson H (2022) Did ketogenic diet in past centuries protect against the consequence of the cystatin L68Q mutation in carriers of HccaA? Laeknabladid 108:553\u2013557. https:\/\/doi.org\/10.17992\/lbl.2022.12.721","journal-title":"Laeknabladid"},{"key":"2233_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1750-3639.2006.tb00561.x","volume":"16","author":"A Palsdottir","year":"2006","unstructured":"Palsdottir A, Snorradottir AO, Thorsteinsson L (2006) Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects. Brain Pathol 16:55\u201359. https:\/\/doi.org\/10.1111\/j.1750-3639.2006.tb00561.x","journal-title":"Brain Pathol"},{"key":"2233_CR42","first-page":"5961","volume":"15","author":"SW Rabkin","year":"2023","unstructured":"Rabkin SW (2023) Collagen type IV as the link between arterial stiffness and dementia. Am J Transl Res 15:5961\u20135971","journal-title":"Am J Transl Res"},{"key":"2233_CR43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"key":"2233_CR44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/jamaneurol.2025.0326","volume":"82","author":"AO Snorradottir","year":"2025","unstructured":"Snorradottir AO, Gutierrez-Uzquiza A, Bragado P, March ME, Kao C, Arkink EB, Jonsdottir S, Sigurdardottir A, Isaksson HJ, Mariasdottir HL et al (2025) N-acetylcysteine for hereditary cystatin C amyloid angiopathy: a nonrandomized clinical trial. JAMA Neurol 82:486\u2013494. https:\/\/doi.org\/10.1001\/jamaneurol.2025.0326","journal-title":"JAMA Neurol"},{"key":"2233_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13291","author":"AO Snorradottir","year":"2024","unstructured":"Snorradottir AO, Hakonarson H, Palsdottir A (2024) The historical background of hereditary cystatin C amyloid angiopathy: genealogical, pathological, and clinical manifestations. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.13291","journal-title":"Brain Pathol"},{"key":"2233_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13291","volume":"35","author":"AO Snorradottir","year":"2025","unstructured":"Snorradottir AO, Hakonarson H, Palsdottir A (2025) The historical background of hereditary cystatin C amyloid angiopathy: genealogical, pathological, and clinical manifestations. Brain Pathol 35:e13291. https:\/\/doi.org\/10.1111\/bpa.13291","journal-title":"Brain Pathol"},{"key":"2233_CR47","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/labinvest.2016.133","volume":"97","author":"AO Snorradottir","year":"2017","unstructured":"Snorradottir AO, Isaksson HJ, Ingthorsson S, Olafsson E, Palsdottir A, Bragason BT (2017) Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy. Lab Invest 97:383\u2013394. https:\/\/doi.org\/10.1038\/labinvest.2016.133","journal-title":"Lab Invest"},{"key":"2233_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.brainres.2013.08.029","volume":"1535","author":"AO Snorradottir","year":"2013","unstructured":"Snorradottir AO, Isaksson HJ, Kaeser SA, Skodras AA, Olafsson E, Palsdottir A, Bragason BT (2013) Deposition of collagen IV and aggrecan in leptomeningeal arteries of hereditary brain haemorrhage with amyloidosis. Brain Res 1535:106\u2013114. https:\/\/doi.org\/10.1016\/j.brainres.2013.08.029","journal-title":"Brain Res"},{"key":"2233_CR49","doi-asserted-by":"publisher","first-page":"R844","DOI":"10.1186\/bcr1312","volume":"7","author":"JP Sokol","year":"2005","unstructured":"Sokol JP, Neil JR, Schiemann BJ, Schiemann WP (2005) The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta. Breast Cancer Res 7:R844-853. https:\/\/doi.org\/10.1186\/bcr1312","journal-title":"Breast Cancer Res"},{"key":"2233_CR50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1158\/1541-7786.183.2.3","volume":"2","author":"JP Sokol","year":"2004","unstructured":"Sokol JP, Schiemann WP (2004) Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. Mol Cancer Res 2:183\u2013195","journal-title":"Mol Cancer Res"},{"key":"2233_CR51","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3892\/mmr.2014.2261","volume":"10","author":"P Song","year":"2014","unstructured":"Song P, Zheng JX, Liu JZ, Xu J, Wu LY, Liu C, Zhu Q, Wang Y (2014) Effect of the Wnt1\/beta-catenin signalling pathway on human embryonic pulmonary fibroblasts. Mol Med Rep 10:1030\u20131036. https:\/\/doi.org\/10.3892\/mmr.2014.2261","journal-title":"Mol Med Rep"},{"key":"2233_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.599415","volume":"11","author":"V Sorokin","year":"2020","unstructured":"Sorokin V, Vickneson K, Kofidis T, Woo CC, Lin XY, Foo R, Shanahan CM (2020) Role of vascular smooth muscle cell plasticity and interactions in vessel wall inflammation. Front Immunol 11:599415. https:\/\/doi.org\/10.3389\/fimmu.2020.599415","journal-title":"Front Immunol"},{"key":"2233_CR53","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV et al (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11:457\u2013470. https:\/\/doi.org\/10.1038\/nrneurol.2015.119","journal-title":"Nat Rev Neurol"},{"key":"2233_CR54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR, Ghebremedhin E, Rub U, Yamaguchi H, Del Tredici K, Braak H (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61:282\u2013293. https:\/\/doi.org\/10.1093\/jnen\/61.3.282","journal-title":"J Neuropathol Exp Neurol"},{"key":"2233_CR55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","volume":"115","author":"DR Thal","year":"2008","unstructured":"Thal DR, Griffin WS, de Vos RA, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease. Acta Neuropathol 115:599\u2013609. https:\/\/doi.org\/10.1007\/s00401-008-0366-2","journal-title":"Acta Neuropathol"},{"key":"2233_CR56","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1177\/0271678X17722436","volume":"37","author":"MS Thomsen","year":"2017","unstructured":"Thomsen MS, Routhe LJ, Moos T (2017) The vascular basement membrane in the healthy and pathological brain. J Cereb Blood Flow Metab 37:3300\u20133317. https:\/\/doi.org\/10.1177\/0271678X17722436","journal-title":"J Cereb Blood Flow Metab"},{"key":"2233_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0022-510x(92)90042-j","volume":"108","author":"L Thorsteinsson","year":"1992","unstructured":"Thorsteinsson L, Georgsson G, Asgeirsson B, Bjarnadottir M, Olafsson I, Jensson O, Gudmundsson G (1992) On the role of monocytes\/macrophages in the pathogenesis of central nervous system lesions in hereditary cystatin C amyloid angiopathy. J Neurol Sci 108:121\u2013128. https:\/\/doi.org\/10.1016\/0022-510x(92)90042-j","journal-title":"J Neurol Sci"},{"key":"2233_CR58","doi-asserted-by":"publisher","unstructured":"Tumer N, Toklu HZ, Muller-Delp JM, Oktay S, Ghosh P, Strang K, Delp MD, Scarpace PJ (2014) The effects of aging on the functional and structural properties of the rat basilar artery. Physiol Rep https:\/\/doi.org\/10.14814\/phy2.12031","DOI":"10.14814\/phy2.12031"},{"key":"2233_CR59","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/s1474-4422(03)00484-8","volume":"2","author":"J van Horssen","year":"2003","unstructured":"van Horssen J, Wesseling P, van den Heuvel LP, de Waal RM, Verbeek MM (2003) Heparan sulphate proteoglycans in Alzheimer\u2019s disease and amyloid-related disorders. Lancet Neurol 2:482\u2013492. https:\/\/doi.org\/10.1016\/s1474-4422(03)00484-8","journal-title":"Lancet Neurol"},{"key":"2233_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70254","volume":"21","author":"L Ventura-Antunes","year":"2025","unstructured":"Ventura-Antunes L, Nackenoff A, Romero-Fernandez W, Wang Y, Bosworth AM, Prusky A, Wang E, Carvajal-Tapia C, Shostak A, Harmsen H et al (2025) Arteriolar degeneration and stiffness in cerebral amyloid angiopathy are linked to Abeta deposition and lysyl oxidase. Alzheimers Dement 21:e70254. https:\/\/doi.org\/10.1002\/alz.70254","journal-title":"Alzheimers Dement"},{"key":"2233_CR61","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ana.410300503","volume":"30","author":"JP Vonsattel","year":"1991","unstructured":"Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. (1991) Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 30:637\u2013649. https:\/\/doi.org\/10.1002\/ana.410300503","journal-title":"Ann Neurol"},{"key":"2233_CR62","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.ajpath.2017.07.018","volume":"187","author":"Z Wei","year":"2017","unstructured":"Wei Z, Caty J, Whitson J, Zhang AD, Srinivasagan R, Kavanagh TJ, Yan H, Fan X (2017) Reduced glutathione level promotes epithelial-mesenchymal transition in lens epithelial cells via a Wnt\/beta-catenin-mediated pathway: relevance for cataract therapy. Am J Pathol 187:2399\u20132412. https:\/\/doi.org\/10.1016\/j.ajpath.2017.07.018","journal-title":"Am J Pathol"},{"key":"2233_CR63","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","volume":"18","author":"RO Weller","year":"2008","unstructured":"Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease. Brain Pathol 18:253\u2013266. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00133.x","journal-title":"Brain Pathol"},{"key":"2233_CR64","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0002-9440(10)64713-x","volume":"156","author":"T Wyss-Coray","year":"2000","unstructured":"Wyss-Coray T, Lin C, Sanan DA, Mucke L, Masliah E (2000) Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer\u2019s disease-like microvascular degeneration in transgenic mice. Am J Pathol 156:139\u2013150. https:\/\/doi.org\/10.1016\/s0002-9440(10)64713-x","journal-title":"Am J Pathol"},{"key":"2233_CR65","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004911","author":"PD Yurchenco","year":"2011","unstructured":"Yurchenco PD (2011) Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a004911","journal-title":"Cold Spring Harb Perspect Biol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02233-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02233-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02233-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:01:43Z","timestamp":1772701303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02233-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2233"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02233-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the National Bioethics Committee of Iceland (permit nos. 15-060 and 2411044) and the Biobank of the Department of Pathology at Landsp\u00edtali University Hospital (permit nos. L-01-22 and L-01-25). Individual participation consent is not applicable, as all materials analyzed were obtained post-mortem during diagnostic autopsies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr Hakonarson is the founder of and holds equity in Arctic Therapeutics developing NAC and NACA for HCCAA and AD. Drs. Hakonarson and Snorradottir have filed patent application for therapeutic interventions of HCCAA and AD. No other disclosures are reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}